|Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies|
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
|Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype|
SR Lakhani, JS Reis-Filho, L Fulford, F Penault-Llorca, M van der Vijver, ...
Clinical cancer research 11 (14), 5175-5180, 2005
|Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts|
HFA Vasen, I Blanco, K Aktan-Collan, JP Gopie, A Alonso, S Aretz, ...
Gut 62 (6), 812-823, 2013
|Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service|
DG Evans, E Howard, C Giblin, T Clancy, H Spencer, SM Huson, F Lalloo
American journal of medical genetics Part A 152 (2), 327-332, 2010
|The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions|
AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ...
British journal of cancer 98 (8), 1457-1466, 2008
|Germline mutations in RAD51D confer susceptibility to ovarian cancer|
C Loveday, C Turnbull, E Ramsay, D Hughes, E Ruark, JR Frankum, ...
Nature genetics 43 (9), 879-882, 2011
|Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD|
CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ...
Human mutation 31 (1), 41-51, 2010
|Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme|
E Amir, DG Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, ...
Journal of medical genetics 40 (11), 807-814, 2003
|Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations|
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, ...
Clinical genetics 75 (2), 141-149, 2009
|Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database|
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
|Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk|
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS Genet 9 (3), e1003212, 2013
|A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO|
DGR Evans, DM Eccles, N Rahman, K Young, M Bulman, E Amir, ...
Journal of medical genetics 41 (6), 474-480, 2004
|Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database|
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
|Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations|
A Moran, C O’hara, S Khan, L Shack, E Woodward, ER Maher, F Lalloo, ...
Familial cancer 11 (2), 235-242, 2012
|Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction|
AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ...
Cancer research 70 (23), 9742-9754, 2010
|Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer|
E Ruark, K Snape, P Humburg, C Loveday, I Bajrami, R Brough, ...
Nature 493 (7432), 406-410, 2013
|Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer …|
DG Evans, A Shenton, E Woodward, F Lalloo, A Howell, ER Maher
BMC cancer 8 (1), 1-9, 2008
|Familial breast cancer|
F Lalloo, DG Evans
Clinical genetics 82 (2), 105-114, 2012
|Prediction of pathogenic mutations in patients with early-onset breast cancer by family history|
F Lalloo, J Varley, D Ellis, A Moran, L O'Dair, P Pharoah, DGR Evans, ...
The Lancet 361 (9363), 1101-1102, 2003
|Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study|
SL Neuhausen, AK Godwin, R Gershoni-Baruch, E Schubert, J Garber, ...
The American Journal of Human Genetics 62 (6), 1381-1388, 1998